Atrophy rates accelerate in amnestic mild cognitive impairment. - Wikidata - awgldk - TriplyDB

Atrophy rates accelerate in amnestic mild cognitive impairment.

Atrophy rates accelerate in amnestic mild cognitive impairment.

http://www.wikidata.org/entity/Q30489846

about

The clinical use of structural MRI in Alzheimer disease Brain imaging in Alzheimer disease Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease Ushering in the study and treatment of preclinical Alzheimer disease Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Neuroanatomical substrates of age-related cognitive decline Cognitive correlates of cross-sectional differences and longitudinal changes in trail making performance Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data.Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models.The common dementias: a pictorial review.Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Event time analysis of longitudinal neuroimage data.Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.Brain imaging in dementia.Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.Progression of atrophy in Alzheimer's disease and related disorders.Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Rates of decline in Alzheimer disease decrease with age.A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.Nonlinear time course of brain volume loss in cognitively normal and impaired elders Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry Mapping ventricular expansion onto cortical gray matter in older adults.Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.Early diagnosis of Alzheimer's disease: is MCI too late?Emerging biomarkers in cognition.The dynamics of cortical and hippocampal atrophy in Alzheimer disease.Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.

P2860

Q24609648-71A6E5EE-650D-439B-AF3E-EC488B30F3D7 Q26996299-283E3926-15A2-4DC4-A6BA-225B1A7A71C7 Q27009241-11E22990-17C8-4296-B8A3-1B808DBB21CF Q27014791-AB7C6343-ACE6-474B-AA6A-F7AB8515B9DC Q29620245-6152D28F-01B1-4E1D-BE5C-7A07A732A795 Q30425315-6B5EA75D-86DE-46F8-9AF6-0C2497921226 Q30428566-4C8CBB98-C1BB-467D-B464-F5D411AC36BF Q30486156-552FD35F-09CD-4546-8AF9-5FFD21EEC46E Q30576007-427370F4-787A-4CBE-85A4-5E7066DE27B3 Q30670885-5830E7BC-750A-4680-9909-0D33996B52CB Q30765803-DD20398A-A514-438F-9B8C-96426C118ABC Q30801659-4B312B6E-9520-45DA-9946-2EA95DFC24A0 Q30996675-F9CE503A-B9BB-476D-930E-8336125FFFBD Q31051218-94A34D59-1520-46FA-88E2-9C1A7173B13B Q33540910-E44DA8F2-C8C6-4D89-8C74-5AF46F3B6EEC Q33547491-DBFF771F-C938-4AD3-934E-CF72D382A312 Q33556006-29FD1D67-0294-4B48-A172-6A4BDFFC42D7 Q33652639-BFF8AC8A-8A74-4594-BA42-505490BDDBBC Q33687554-5DCE21E1-0646-41C6-A1A5-FB73D84A31BF Q33689474-1CE33595-76A7-4333-BDE5-E204F724DFE8 Q33729033-8F13AC91-40A7-44C4-B96D-ACAA08F53464 Q33841363-707C6DA9-F76C-4443-A150-1AFCCCFB2740 Q33987747-BA822C48-C675-470D-926D-553A1D3F8AED Q33996059-D844937F-2D0E-4CC2-B43E-3538660C083F Q34039952-0CEDE0EC-8EF6-40D9-8344-C9DCE748D894 Q34052882-48B1EC53-EFBC-461B-962C-1BD9A00F6D71 Q34081087-511743DC-A5AF-4F96-8080-50A6BDD2E140 Q34183016-6E00A7CC-A896-4283-AA9D-A568D1B180FC Q34372593-DA3AC3D9-E98C-4E52-A372-476CAB91DBB9 Q34469900-65B08312-88EC-47C2-95A7-8DB2CF2905E5 Q34473063-0EA3EADB-2617-4F51-82F1-C0FCFE7413E0 Q34544193-566D2166-DE4D-416A-BC17-37198D48649B Q34615211-3CB65D2D-2607-4B84-9FD6-1B243ABB8D49 Q34714892-C92372F1-8322-4628-B39C-23DA2450D646 Q34746717-0B318FE5-5A76-4953-B209-E2D3946BC2E7 Q34754658-85B39801-73E9-4CC4-A240-592609679DE9 Q34992855-500A6179-C421-4209-9E40-E75E17EC80DD Q35008258-B9A5E9B8-3C06-44EA-A852-C272466F12ED Q35643088-4FA86273-C80C-4DCB-8F3F-E7696F4AA192 Q35738877-E41A720F-7BB8-4F8C-88E1-1DE5090CD8CB

P2860

Atrophy rates accelerate in amnestic mild cognitive impairment.

http://www.wikidata.org/entity/Q30489846

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Atrophy rates accelerate in amnestic mild cognitive impairment.

@ast

Atrophy rates accelerate in amnestic mild cognitive impairment.

@en

type

label

Atrophy rates accelerate in amnestic mild cognitive impairment.

@ast

Atrophy rates accelerate in amnestic mild cognitive impairment.

@en

prefLabel

Atrophy rates accelerate in amnestic mild cognitive impairment.

@ast

Atrophy rates accelerate in amnestic mild cognitive impairment.

@en

P1433

Q30489846-C540F72A-685C-4343-B538-0E50D2922F49

P1476

Q30489846-E04D713D-9EB5-43B5-9EB7-5290B4BFF969

P2093

Q30489846-14ED9BF4-0FA9-4399-ACD3-05955F9034A9

Q30489846-19964571-BB0C-4BA6-9B72-B65CBC9FB612

Q30489846-22966456-8811-4062-9272-C1E0C34BB05E

Q30489846-30260C6F-58F9-4D5D-87A8-4F734224EE5E

Q30489846-5C7E9F51-2D93-410E-875C-A8A876672D45

Q30489846-928BA3ED-F573-4DB8-97F0-549177F6AED6

Q30489846-94E15A61-9FBE-4282-A40F-DBF515DA7B36

Q30489846-AE379767-E351-4C8A-9493-2456E56AFC26

Q30489846-B08D4B4E-B297-46E5-A6D0-32EACF532E56

Q30489846-DDED3836-549F-427F-8FED-A8A8BF1633C3

P2860

Q30489846-007D3DF6-BB52-4266-8216-440096F2CEFA

Q30489846-010F003D-5165-45B7-BAF6-851017E27C50

Q30489846-06018E2C-DBD3-425E-B6C4-9988601DFBDF

Q30489846-0C7EE61F-3ED7-498F-A10B-2C02AD19CDEE

Q30489846-0FC53778-9B1D-477B-8E34-873A0A9B90DE

Q30489846-105CFC5D-7DE1-4F47-8042-056D067EA504

Q30489846-10A06B40-872A-4648-B1E1-89925D5C7995

Q30489846-16BC4DC7-0815-4EEF-A909-AE1F453B35C0

Q30489846-262043B3-4C5E-40FF-8D86-ADF4F0B76DCF

Q30489846-28FA02F8-1AC4-4406-A901-48F5EB064737

P304

Q30489846-D7E1EF60-AE3A-4863-B62C-EEE8834E4467

P31

Q30489846-2CC5E881-3DB5-4853-B97D-B5B67BCE494A

P356

Q30489846-D05AA5AD-B83D-41A8-81CE-CAB8BE78C19D

P407

Q30489846-AE6E7666-38FD-4BEC-B7DD-F00612B7FCC7

P433

Q30489846-80E7143F-2274-410A-8F56-B00609313A8E

P478

Q30489846-7BCC1A11-2C0B-4836-A75A-581BBA45D149

P577

Q30489846-5DDD405A-9E56-4C8F-B65D-7E5CCBFD956A

P5875

Q30489846-44EDB367-1B02-470D-9742-AFA525AB7795

P698

Q30489846-37758427-B554-4BFD-95B4-44B0C68649D0

P932

Q30489846-EAFFB7B5-F50C-4ADC-A15B-9940A18A2058

P356

01.WNL.0000281688.77598.35

P1433

P1476

Atrophy rates accelerate in amnestic mild cognitive impairment.

@en

P2093

B F Boeve

http://www.w3.org/2001/XMLSchema#string

C R Jack

http://www.w3.org/2001/XMLSchema#string

D S Knopman

http://www.w3.org/2001/XMLSchema#string

G E Smith

http://www.w3.org/2001/XMLSchema#string

J L Gunter

http://www.w3.org/2001/XMLSchema#string

M M Shiung

http://www.w3.org/2001/XMLSchema#string

P C O'Brien

http://www.w3.org/2001/XMLSchema#string

R C Petersen

http://www.w3.org/2001/XMLSchema#string

S A Przybelski

http://www.w3.org/2001/XMLSchema#string

S D Weigand

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

“Mini-mental state”

Mild cognitive impairment: clinical characterization and outcome

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

The Clinical Dementia Rating (CDR): current version and scoring rules

Staging of Alzheimer-related cortical destruction.

Regional brain changes in aging healthy adults: general trends, individual differences and modifiers.

Higher atrophy rate of entorhinal cortex than hippocampus in AD.

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Atrophy rates of entorhinal cortex in AD and normal aging.

P304

1740-1752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000281688.77598.35

http://www.w3.org/2001/XMLSchema#string

P407

P433

19 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5814354

http://www.w3.org/2001/XMLSchema#string

P698

18032747

http://www.w3.org/2001/XMLSchema#string

P932

2734477

http://www.w3.org/2001/XMLSchema#string